Definitive Contract HHSN261200900046C

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles. The contract, valued at $199,981, is for the development of nanoparticle-enabled single cell mass spectrometry technology for the detection of rare cells, under SBIR Topic 266. As a small business, Nanocomposix has been awarded previous prime...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Department of Health and Human Services (HHS) to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, a small business provider of biomedical research tools and testing equipment. The $145,089 fixed-price contract is for the development of an "Antibody Array for Early Detection of Lung Cancer." Meso Scale Diagnostics specializes in enabling biomarker detection platforms and has...

This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI) to Meso Scale Diagnostics, LLC for the development of an antibody array to detect lung cancer. The $799,999.00 cost-plus-fixed-fee contract has a period of performance ending on July 31, 2013. Meso Scale Diagnostics, a small business, will be conducting the research and development work. The contract includes two key subcontractors, New York University School of Medicine, which...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Nanotarget LLC for the development of a nanoparticle CD8 T cell regimen for cancer therapy. The firm-fixed-price contract has a ceiling value of $174,251 and a period of performance ending on May 31, 2010. No subcontractors are mentioned. The SBIR program supports research and development of innovative technologies by small businesses to address key...

This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Department of Health and Human Services (HHS) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles, for the development of "small hollow nanodelivery vehicles for cancer treatment." The fixed-price contract has a ceiling value of $200,000.00 and a period of performance ending on March 30, 2010. Nanocomposix has previously performed prime contracts and subcontracts for...

<p>The National Cancer Institute (NCI) awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Nanoscale Corporation for the development of a rapid in vitro screening assay to detect cancer biomarkers in urine and blood. The $150,000.00 firm-fixed-price contract has a completion date of May 2, 2013. This SBIR contract is part of the NCI's efforts to support small businesses in the development of innovative cancer-related technologies.</p>

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Synergene Therapeutics Inc. The $199,735 fixed-price contract is for the development of &quot;Targeted Nanocomplexed Iron Oxide for Early Detection with Hyperthermia Treatment of Cancer.&quot; The contract has a period of performance ending on March 30, 2010. As an SBIR Phase I award, this contract is intended to support the small business in exploring the...

This is a $200,000.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Nanomaterial Innovation LTD, a woman-owned limited liability company. The contract is for the development of &quot;MULTIFUNCTIONAL SIRNA NANOPARTICLES FOR AML THERAPY&quot;, which aligns with NCI's research focus on cancer therapeutics. The contract has a firm fixed price pricing type and was awarded on September 24, 2010 with a...

This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Nanoscale Corporation. The $831,900 contract is for the development of &quot;functionalized bimagnetic core/shell Fe/Fe3O4 stealth nanoparticles&quot; for the diagnosis and treatment of cancer. The contract includes two major subcontractors - Xenometrics, LLC, which will conduct toxicology testing, and the...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services (HHS) to Liquidia Technologies, Inc., a small disadvantaged business based in Morrisville, North Carolina. The $140,760 firm-fixed-price contract is for the development of &quot;Targeted Cancer Therapeutics via Print Nanoparticles&quot; under SBIR Topic 241. This Phase I SBIR contract has a completion date of June 27, 2008. Liquidia Technologies has also received other...